3.15 (-3.08%)

T-O: 0.0 (08:59:00)
Last updated: 17:00

Fundamental   5.6  
Technical   2.9  
Total Score   8.5  

 Insti+   MT-   ST- 


iSaham Fundamental Trend

FCON: 0.64 | Sharpe Ratio: 0.76 | LTS: 8.21

Quarter Reports

Trailing Dividend

Financial Ratios

EPS 11.79 sen
Trailing PE (Sector Median: 21.4) 26.7
PEG 2.97
Altman Z 2.7
Beaver 0.559
Current Ratio 2.82
Debt-Equity (DE) Ratio 0.33
FCF Yield 4.65 %
Revenue QoQ -5.31 %
Revenue YoY 1.44 %
Profit QoQ 2.78 %
Profit YoY 6.2 %
Profit Margin (Sector Median: 4.6) 8.02 %
ROE (ROIC: 11.97) 11.97 %
Dividend Per Share (DPS) 4.5 sen
Dividend Yield (DY) 1.43 %

Fair Value

Weighted Average Fair Value: 3.14

Discounted Cash Flow (DCF) 5% Growth 1.13
Discounted Cash Flow (DCF) 10% Growth 1.49
Relative Valuation 2.52
Average Analysts FV based on 3 rating(s), -8.3% 2.89
Graham Formula 0.89
Graham Number 1.62
Net Tangible Asset (NTA) 0.0
Consistent QR FV N/APremium Access Only

Advanced Calculators

Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.

Forward PE FV Calculator
Latest Profit 14.39
Expected Profit (Next QR) [M]
Expected Profit (After QR above) [M]
Expected Profit (After QR above) [M]
Estimated Fair Value
Growth/Risk Fair Value Calculator
Expected growth (%)
Estimated downside / risk (%)
Estimated New DCF Fair Value
Contract/Award Contribution Calculator
Contract/Award Value (in Million)
Estimated Contribution to Stock Price
Estimated New DCF Fair Value
Profit-Based Calculator
Expected Profit (M)
for Year
Estimated New DCF Fair Value
Revenue-Based Calculator
Expected Revenue (M)
for Year
Estimated New DCF Fair Value
Market Pricing
Expected Profit (M) 283.28
Expected Revenue (M) 3532.18
Expected Growth (%) 27.0

Directors Share Purchases (Beta)

MR KEE KIRK CHUEN added 104000.0 units on 26 Jan 2021 at RM3.35

DR KEE KIRK CHIN added 104000.0 units on 26 Jan 2021 at RM3.35



Market Cap: 1496 M.

Number of Shares: 475 M.

Adjusted Float: 15.78%.

Stock highly correlated with



BPPLAS (95%)

FBMACE (95%)

Manipulation Indicator: Very hard to manipulate.

Apex Healthcare Berhad is a leading healthcare group with operations in Malaysia, Singapore, Vietnam and Myanmar. Founded in 1962, our core expertise is in the development, manufacturing, sales and marketing, distribution and wholesaling of pharmaceuticals, consumer healthcare products and diagnostics. Apex Healthcare Berhad is publicly listed on the Main Market of Bursa Malaysia.

Sectors: Pharmaceuticals, Healthcare

Code: 7090

Website: http://www.apexhealthcare.com.my/

Related Links: Bursa | Annual Report | Announcement

Top Shareholdings

Updated on 12-May-2020

Shareholder Value (M)
Apex Pharmacy Holdings Sendirian Berhad 599.41
Washington H.Soul Pattinson And Company Limited 446.83
Md Ali Bin Md Dewal 25.2
Liew Yoon Yee 22.68
Lim Teh Realty Sdn Berhad 20.48
DBS Bank Ltd 11.97
Tan Yan Meng Warren 11.93
Xepa Holding Sdn Bhd 11.21
Fidelity Series Intrinsic Opportunities Fund 9.45
Chan Heng Koon 7.82
Teoh Choon Neo @ Ivy Teoh Choon Neo 7.56
PB Islamic Smallcap Fund 7.43
Singam A/L Kumarasamy 7.13
Apex Holdings (Pte) Ltd 6.0
Fidelity Northstar Fund 5.98
Yeo Lee Hee 5.9
Osk Technology Ventures Sdn. Bhd. 5.49
National Trust Fund 5.07
Wong Yee Hui 5.04
Oh Siew Heong 5.04
Icapital.biz Berhad 4.41
Susy Ding 4.09
Manulife Investment Progress Fund 4.0
Leong Khai Cheong 3.97
Kee Kirk Chin 3.78
Tan Jin Thai 3.78
Leong Wai Kuen 3.69